Alpha 2.0
Login Register
» Articles » PMID: 31416952

Downgrading of Regulation in Regenerative Medicine

Overview
Journal Science
Specialty Science
Date 2019 Aug 17
PMID 31416952
Citations 7
Authors
Douglas Sipp
Margaret Sleeboom-Faulkner
Affiliations
Soon will be listed here.
Citing Articles

Polish regulatory system regarding ATMP hospital exemptions.

Pachocki J, Verter F Front Immunol. 2024; 15:1379134.

PMID: 38803487 PMC: 11128580. DOI: 10.3389/fimmu.2024.1379134.

US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation.

Matthews K, Lowe S, Master Z Cytotherapy. 2024; 26(4):404-409.

PMID: 38310500 PMC: 11010147. DOI: 10.1016/j.jcyt.2024.01.002.

The evolving regulatory landscape in regenerative medicine.

Beetler D, Di Florio D, Law E, Groen C, Windebank A, Peterson Q Mol Aspects Med. 2022; 91:101138.

PMID: 36050142 PMC: 10162454. DOI: 10.1016/j.mam.2022.101138.

Unproven stem cell interventions: A global public health problem requiring global deliberation.

Master Z, Matthews K, Abou-El-Enein M Stem Cell Reports. 2021; 16(6):1435-1445.

PMID: 34107243 PMC: 8190665. DOI: 10.1016/j.stemcr.2021.05.004.

ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.

Turner L Stem Cell Reports. 2021; 16(6):1394-1397.

PMID: 34048693 PMC: 8190662. DOI: 10.1016/j.stemcr.2021.05.011.